Although others published a prognostic value for CD73 in predicting OS and DFS in the TCGA-HNSCC cohort, we did not observe any significant difference in n = 415 HPV-negative HNSCC patients with respect to CD73 expression levels (Fig. 7A–C). Here, NT5E is linked to head and neck squamous cell carcinoma.